Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Type 2 Diabetes on CYP450 Activities
NCT02291666Phase 4Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Apr 2015
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial (3 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Metabolic ratio at 12 hours. Started Apr 2015; status: completed.
Beyond the preview
Go deeper on NCT02291666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291666.